India Medical Devices Market By Type (Cardiovascular Devices, Diagnostic Imaging Equipment, In-vitro Diagnostic Devices, Ophthalmic Devices, Diabetes Care Devices, Dental Care Devices, Surgical Equipment, Patient Monitoring Devices, Orthopedic Devices, Nephrology & Urology Devices, ENT Devices, Anesthesia & Respiratory Devices, Neurology Devices, Mobility-Aid Devices, Others), By End User (Hospitals & Clinics, Diagnostic Centers, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

India Medical Devices Market is projected to grow from USD 16.17 Billion in 2024 to USD 22.30 Billion by 2030 at a 5.46% CAGR. Medical devices are instruments, machines, apparatuses, implants, or similar devices designed to diagnose, monitor, treat, or prevent diseases, injuries, or other medical conditions. They play a vital role in healthcare, aiding healthcare professionals in diagnosing and treating patients and assisting individuals in managing their health. Medical devices can vary greatly in complexity, purpose, and application.  India's rising healthcare expenditure, both by the government and private sector, has been a major driver. The government's initiatives, such as the Ayushman Bharat program, have significantly increased healthcare funding, leading to greater demand for medical devices. India has become a preferred destination for medical tourism due to the availability of high-quality healthcare services at a lower cost. Medical tourists require advanced medical devices and treatments, boosting market growth.

For instance, in May 2025, Fortis Mohali introduced advanced clot retrieval devices for treating vascular-related disorders. These cutting-edge technologies significantly reduced the risk of bleeding, improved patient safety, and enabled faster recovery. The hospital’s adoption of these devices marked a significant advancement in minimally invasive treatment options, offering more effective outcomes for patients with critical vascular conditions. Expanding healthcare services in rural areas is a priority, and this requires equipping healthcare facilities with medical devices suitable for remote and underserved regions. Advances in medical technology, including point-of-care testing, minimally invasive surgery, and wearable devices, have driven the adoption of innovative medical devices in the Indian market. Increasing patient awareness about healthcare options and the benefits of early diagnosis has driven demand for diagnostic and monitoring devices. The presence of multinational medical device companies in India has not only increased competition but also brought advanced technologies and products to the market.

Key Market Drivers

Innovations in Technology

Medical devices such as ultrasound machines, ECG monitors, and surgical tools are becoming smaller and more portable, enabling point-of-care testing and flexible healthcare delivery. Wearable technologies including fitness trackers, smartwatches, and health monitors allow real-time tracking of heart rate, sleep, and physical activity, empowering individuals to manage their health proactively. Telemedicine platforms and remote monitoring now support virtual consultations and home-based data sharing, improving access and enabling timely interventions.

Advances in imaging, including 3D and 4D imaging, functional MRI, and PET-CT scans, are enhancing diagnostic precision and early disease detection. AI and machine learning analyze vast medical datasets to support diagnosis, predict disease progression, and personalize treatment. Robotic-assisted surgery offers greater precision and minimally invasive procedures, reducing recovery time.

Nanotechnology enables targeted drug delivery and miniature sensors, while 3D bioprinting supports tissue engineering and the potential creation of organs. Smart implantable devices, such as pacemakers and cochlear implants, transmit real-time data via mobile apps. POCT devices provide rapid diagnostics, especially in emergencies and resource-limited areas. Tiny medical robots, advanced prosthetics, implantable sensors, CRISPR gene editing, and blockchain-based data security are further transforming care, collectively accelerating innovation and strengthening the India Medical Devices Market.

Rural Healthcare Expansion

Rural healthcare expansion focuses on improving access for underserved populations by deploying medical devices in remote settings to ensure equitable care. In January 2025, India’s Central Drugs Standard Control Organization (CDSCO) announced plans to ban imports of pre-owned and refurbished medical devices, aiming to enhance patient safety, uphold quality standards, and boost domestic manufacturing. Industry experts viewed this as a catalyst for innovation, stronger regulatory oversight, and a reinforced global position for India’s medical device sector.

Rural regions face a high burden of communicable and non-communicable diseases, driving demand for diagnostic, monitoring, and treatment devices. Preventive care and early detection initiatives increase the need for screening, vaccination, and health-promotion tools. Telemedicine and mobile health solutions link rural patients with providers through remote monitoring devices and telehealth platforms.

Maternal and child healthcare requires ultrasound machines, incubators, and monitoring equipment, while emergency care depends on portable defibrillators, mobile X-ray units, and tele-consultations. Chronic disease management fuels demand for diabetes, hypertension, and respiratory devices. Diagnostic centers procure X-ray, ultrasound, lab equipment, and POCT devices for rapid testing. Dental, ophthalmic, and community health programs further expand device usage—supported by initiatives like India’s National Rural Health Mission (NRHM) collectively accelerating growth in the India Medical Devices Market.

Increasing Patient Awareness

India’s evolving manufacturing and trade initiatives, including Make in India, the PLI scheme, the National Medical Devices Policy 2023, and CDSCO’s global alignment, are strengthening domestic medical device production while increasing patient awareness. Greater access to affordable, high-quality technologies empowers patients to make informed healthcare decisions and actively participate in preventive care through regular check-ups and screenings driving demand for diagnostic and monitoring devices.

Awareness of early disease detection encourages higher utilization of imaging and diagnostic equipment. Patients increasingly adopt wearables and home monitoring tools to track vital signs, manage chronic conditions, and seek timely intervention. Informed individuals engage more effectively in self-care, using devices such as glucometers, inhalers, insulin pumps, and CPAP machines, while adherence to prescribed therapies further supports device adoption.

Educated patients also participate in shared decision-making, influencing device selection and treatment pathways. Growing familiarity with telemedicine promotes virtual consultations and remote monitoring, increasing demand for connected medical technologies. Tech-savvy consumers invest in fitness trackers, smart scales, and mobile health apps, expanding the consumer device segment. Participation in clinical trials introduces patients to advanced monitoring tools, aiding innovation. Moreover, informed patients advocate for better access to modern healthcare infrastructure and willingly share health data to enable personalized medicine—collectively accelerating growth in the India Medical Devices Market.

Download Free Sample Report

Key Market Challenges

Price Sensitivity

Many patients in India are price-conscious and seek cost-effective healthcare solutions, which directly shapes the adoption and utilization of medical devices because out-of-pocket spending can be a decisive barrier and both providers and patients often prioritize essential performance at the lowest feasible price point. Affordability therefore becomes a critical selection criterion for hospitals and clinicians, especially in public facilities with fixed budgets and tender-based procurement where unit prices determine how many patients can be treated within available allocations. For instance, the Government of India has used price regulation to keep select high-impact devices affordable, including NPPA-revised ceiling prices effective 1 April 2025 of Rs 10,692.69 for bare metal coronary stents and Rs 38,933.14 for drug eluting stents, which can compress pricing headroom for manufacturers and distributors while improving patient access.

In orthopaedics, NPPA’s continued ceiling-price approach has also been reflected in caps cited for knee replacement systems such as Rs 51,563 for a primary knee replacement system and Rs 83,547 for a revision knee replacement system, reinforcing price-led purchasing decisions in hospitals and among patients. While health insurance coverage is expanding, scheme and product limits still nudge providers toward lower-cost device configurations to keep total procedure costs within payable limits, and under AB-PMJAY the benefit is up to Rs 5,00,000 per family per year for secondary and tertiary hospitalization, so the device choice can materially affect whether a package remains financially viable for the patient and hospital. The scale of publicly financed care further amplifies this price sensitivity because AB-PMJAY had issued more than 42 crore Ayushman cards and empanelled over 33,000 hospitals as of October 2025, making affordability-linked device procurement relevant across a very large treatment network in India.

Quality Control and Counterfeit Products

Substandard or counterfeit medical devices can pose serious risks to patient safety. The use of such products can lead to incorrect diagnoses, treatment complications, and adverse health outcomes. In the past, the regulatory environment in India for medical devices was less stringent, allowing for substandard and counterfeit products to enter the market. While efforts have been made to strengthen regulations, challenges in enforcement persist. The monitoring and surveillance of medical devices post-market can be inadequate. This means that substandard or counterfeit products may go undetected until adverse events occur. India relies on imported medical devices, which can be susceptible to counterfeit products, especially when imported from regions with less stringent quality control standards. The Indian government's push for local manufacturing, as part of the "Make in India" and "Atmanirbhar Bharat" initiatives, aims to reduce dependence on imports. However, this also necessitates a focus on maintaining quality standards in locally manufactured devices.

Key Market Trends

Adoption of Digital Health Solutions

Telemedicine platforms and telehealth services have seen substantial growth in India since the COVID-19 period, enabling remote consultations that reduce the need for in-person visits and improve access, especially where specialist availability is limited. For instance, the Ministry of Health and Family Welfare’s national telemedicine service eSanjeevani had served over 36 crore patients through teleconsultations as of 6 April 2025, illustrating how remote care has scaled for routine OPD needs as well as follow-ups.

This expansion is being reinforced by the Ayushman Bharat Digital Mission infrastructure, with more than 73 crore Ayushman Bharat Health Accounts created as of 20 January 2025 and more than 5 lakh health professionals registered, which helps standardize digital identity and provider availability for online-first care pathways. Electronic health records and health information exchange are also gaining momentum through ABDM-linked records, with PIB reporting over 67 crore ABHA created and more than 42 crore health records linked, along with over 1.3 lakh ABDM-enabled facilities including more than 17,000 private facilities, enabling more consistent digital capture and sharing of patient data for coordinated care.

In parallel, India’s Unified Health Interface and other ABDM building blocks are expanding interoperability, with PIB noting that over 236 private entities are integrated into the ABDM ecosystem, which supports app-based services such as digital OPD registration, digital prescriptions, and lab reports, and reduces test duplication by improving verified data exchange across providers. As these connected records and digital workflows mature, they also strengthen the foundation for remote monitoring, consumer wearables, and AI and machine learning use cases such as medical image analysis and risk prediction by making longitudinal patient data more consistently available for clinical decision support.

Segmental Insights

Type Insights

In 2024, the India Medical Devices Market largest share was held by Diagnostic Imaging Equipment segment and is predicted to continue expanding over the coming years. The prevalence of various diseases, including cardiovascular diseases, cancer, and orthopaedic conditions, has been on the rise in India. Diagnostic imaging equipment plays a critical role in the early detection and diagnosis of these diseases, driving demand for these devices. Diagnostic imaging equipment, such as MRI machines, CT scanners, and X-ray machines, are essential for providing advanced healthcare services. Major hospitals and diagnostic centres rely on these devices for accurate and timely diagnoses, making them a central component of the healthcare infrastructure. India has been investing in expanding its healthcare infrastructure, including the establishment of new hospitals, diagnostic centres, and clinics.

These facilities often prioritize equipping themselves with modern diagnostic imaging equipment to offer comprehensive services. Increasing health insurance coverage in India has made advanced diagnostic procedures more accessible to a larger portion of the population. This has led to an increased utilization of diagnostic imaging equipment in healthcare facilities. Advances in diagnostic imaging technology have made these devices more precise and accessible. Innovations in equipment design, imaging software, and data analysis have improved the accuracy of diagnoses. There is a growing awareness of preventive healthcare in India. Screening and early detection of diseases have become a focal point for both healthcare providers and patients, leading to greater demand for diagnostic imaging equipment.

Download Free Sample Report

Regional Insights

The North India region dominated the India Medical Devices Market in 2024, led by Delhi NCR’s concentration of tertiary hospitals, teaching institutions, and diagnostic hubs that tend to adopt advanced devices earlier and at higher volumes. For instance, Delhi’s Economic Survey reported that total hospital beds in the national capital increased from 48,096 in 2014-15 to 57,194 in the latest fiscal cited in the report, and also noted a wide care footprint comprising 88 hospitals and 17 medical colleges, which typically translates into sustained demand for imaging, critical-care, surgical, and lab devices across public and private procurement. North India’s large urban patient catchments and higher treatment intensity around major referral centers further strengthen device utilization, because higher inpatient and procedure loads require continuous replenishment of consumables and upgrading of capital equipment. India’s inbound patient flows also reinforce Delhi NCR’s hub position, with the Ministry of Tourism’s India Tourism Data Compendium noting that air travel accounted for 79.4 percent of foreign tourist arrivals and 57.2 percent landed in Delhi and Mumbai, while Delhi recorded 1.83 million foreign tourist visits in 2023. Medical tourism adds another demand layer for high-end diagnostics and surgical systems, as government-reported foreign tourist arrivals for medical purposes reached 6,44,387 in 2024 and 1,31,856 during January to April 2025.

Recent Developments

• In Dec 2025, Axio Biosolutions partnered with IIEMS to launch the “STOP THE BLEED” initiative in India, focused on empowering citizens with rapid bleeding-control response and showcasing haemostatic solutions like Axiostat.
• In Dec 2025, Trivitron Healthcare and Dubai-based ResoHealth launched a joint venture called Trivitron Digital.AI, aimed at hospital digitization by connecting diagnostic, clinical, and administrative workflows into a unified platform. The JV is positioned to prioritize Tier-2/Tier-3 hospitals in India and also target other emerging markets.
• In Dec 2025, Healthium MedTech agreed to acquire a controlling stake in Paramount Surgimed, an Indian manufacturer/exporter of surgical blades, scalpels, and dermal biopsy products. Multiple reports note Paramount’s non-surgical businesses (lifestyle/hygiene) will be carved out before completion and retained by the promoter family, keeping the transaction tightly focused on surgical consumables.
• In May 2025, the Technology Development Board (TDB) extended support to S3V Vascular for developing India’s first indigenous stroke treatment device. This initiative aimed to reduce dependence on imports and enhance affordable neurovascular care. The backing marked a significant milestone in promoting homegrown innovation and strengthening India’s capabilities in advanced medical device manufacturing.
• In May 2025, MAHE and BPL Medical Technologies formed a strategic partnership to drive innovation in the medical device sector. The collaboration aimed to combine academic research with industry expertise, fostering the development of advanced, affordable healthcare solutions. This alliance marked a significant step toward strengthening India’s medical technology ecosystem and promoting indigenous innovation in the healthcare sector.
• In March 2025, India developed its first indigenous MRI machine, marking a major milestone in medical technology. The innovation aimed to significantly reduce diagnostic and treatment costs while enhancing accessibility across the country. This achievement was seen as a step toward self-reliance in healthcare technology and reducing dependence on expensive imported imaging equipment.
• In January 2025, a breakthrough treatment for sleep apnea was introduced in India, offering new hope to patients suffering from the condition. According to the ResMed 2024 Global Sleep Survey, 46% of respondents reported a history of Obstructive Sleep Apnea, highlighting the urgent need for innovative solutions to address this widespread and often underdiagnosed sleep disorder.
• In May 2025, domestic medical device firms expressed optimism about the India-UK Free Trade Agreement (FTA). They viewed the deal as a significant opportunity to expand exports, attract foreign investments, and enhance collaboration with UK-based companies. The FTA was seen as a catalyst for growth, boosting India's global competitiveness in the medical device manufacturing sector.

Key Market Players

• Wipro GE Healthcare Pvt. Ltd.
• Mindray Medical India Pvt Ltd
• Siemens India
• Philips India Ltd
• Hitachi Medical Systems India
• Shimadzu India
• Fujifilm India Pvt. Ltd, India
• Medtronic Pvt Ltd
• Johnson & Johnson Medical India Limited
• Abbott India Limited
• Becton, Dickinson Private Limited
• Roche Diagnostics India limited.
• Alcon Laboratories (India) Private Limited
• Carl Zeiss India Private Limited
• Canon Medical India

Report Scope:

In this report, the India Medical Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

•  Medical Devices Market, By Type:

o   Cardiovascular Devices

o   Diagnostic Imaging Equipment

o   In-vitro Diagnostic Devices

o   Ophthalmic Devices

o   Diabetes Care Devices

o   Dental Care Devices

o   Surgical Equipment

o   Patient Monitoring Devices

o   Orthopedic Devices

o   Nephrology & Urology Devices

o   ENT Devices

o   Anesthesia & Respiratory Devices

o   Neurology Devices

o   Mobility-Aid Devices

o   Others

• Medical Devices Market, By End-User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Others

• Medical Devices Market, By region:

o   North India

o   South India

o   East India

o   West India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the India Medical Devices Market.

Available Customizations:

India Medical Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

India Medical Devices  Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]